Last reviewed · How we verify
Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin plus fluorouracil/leucovorin compared with HAIC of oxaliplatin alone in patients with advanced hepatocellular carcinoma (HCC)
Details
| Lead sponsor | Sun Yat-sen University |
|---|---|
| Phase | PHASE2 |
| Status | UNKNOWN |
| Enrolment | 150 |
| Start date | Sat Aug 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Sep 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hepatocellular Carcinoma
Interventions
- Sorafenib
- HAIC of FOLFOX
- HAIC of OXA
Countries
China